← Eichor
Condition: Laminopathies Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Laminopathies

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

The Application of T1 Mapping in Real-World
Phase N/A · 1 location(s) · Chinese Academy of Medical Sciences, Fuwai Hospital · NCT07354646
Molecular and Imaging Studies of Cardiovascular Health and Disease
Phase N/A · 1 location(s) · National Heart Centre Singapore · NCT02804269
Cardiac Magnetic Resonance-Clinical Prediction Model-Dilated Cardiomyopathy
Phase N/A · 1 location(s) · Shandong Provincial Hospital · NCT07527715
Outcome-targeted Therapy: Principle and Outcome Evaluation: Clinical Study and Phenotype-genotype Correlation
Phase 2 · 1 location(s) · National Taiwan University Hospital · NCT06632834
The Effects of Sirolimus in Patients With Dilated Cardiomyopathy Infected With Kaposi Sarcoma-associated Virus
Phase 4 · 1 location(s) · Tongji Hospital · NCT06236022
Protein A Immunoadsorption in Dilated Cardiomyopathy (RPIA-DCM)
NA · 1 location(s) · Union Hospital, Tongji Medical College, Huazhong University · NCT06922851
A Phase 1 Open-Label Study of the Safety of Intravenous Allogeneic Neonatal Mesenchymal Cells (nMSCs) in Young Adult (1A
Phase 1 · 5 location(s) · Emory University · NCT06464588
AI-Enabled Direct-from-ECG Ejection Fraction (EF) Severity Assessment Using COR ECG Wearable Monitor
Phase N/A · 8 location(s) · Peerbridge Health, Inc · NCT06699056
Low Energy Diet and Familial Partial Lipodystrophy
NA · 1 location(s) · Cambridge University Hospitals NHS Foundation Trust · NCT03900286
Safety and Efficacy of Second Infusion of FAP iCDC in End-stage Dilated Cardiomyopathy
Phase 1 · 1 location(s) · Second Affiliated Hospital, School of Medicine, Zhejiang Uni · NCT07516288
Registry for Patients With Lipodystrophy
Phase N/A · 28 location(s) · University of Ulm · NCT03553420
Open-label Extension Study to Evaluate Metreleptin in Patients With Partial Lipodystrophy
Phase 3 · 7 location(s) · Chiesi Farmaceutici S.p.A. · NCT06679270
An AAV Gene Therapy Trial of AFTX-201 in Adults With BAG3-Associated Dilated Cardiomyopathy (DCM)
Phase 1/Phase 2 · 3 location(s) · Affinia Therapeutics · NCT07426419
Therapy to Maintain Remission in Dilated Cardiomyopathy
NA · 1 location(s) · Imperial College London · NCT06091475
Modifying Factors in Striated Muscle Laminopathies
NA · 8 location(s) · Institut National de la Santé Et de la Recherche Médicale, F · NCT05394506
Cardiac Magnetic Resonance for Risk Stratification in Dilated Cardiomyopathy
Phase N/A · 1 location(s) · Chinese Academy of Medical Sciences, Fuwai Hospital · NCT04990297
Study of the Progression of Chronic Cardiovascular Conditions
Phase N/A · 1 location(s) · Prolaio · NCT07420907
Early Treatment With Candesartan vs Placebo in Genetic Carriers of Dilated Cardiomyopathy (EARLY-GENE Trial)
Phase 3 · 1 location(s) · Cristina Avendaño Solá · NCT05321875
Characterization of Patients With Cardiomyopathy to Identify Critical Patients Candidates for Cardiac Transplantation
Phase N/A · 3 location(s) · IRCCS Azienda Ospedaliero-Universitaria di Bologna · NCT06813443
Microvascular Dysfunction Assessment to Predict Left Ventricular Reverse Remodeling
NA · 9 location(s) · Azienda Ospedaliera Universitaria Integrata Verona · NCT06356727
Bromocriptine in Dilated Cardiomyopathy Among Women of Reproductive Age
Phase 3 · 1 location(s) · Jimma University · NCT06250257
Coronary Artery Disease and Coronary Microvascular Disease in Cardiomyopathies Registry
Phase N/A · 1 location(s) · University Hospital, Grenoble · NCT03479580
Efficacy and Safety of Mibavademab in Adult and Pediatric Patients With Generalized Lipodystrophy
Phase 3 · 3 location(s) · Regeneron Pharmaceuticals · NCT07220785
the Clinical Outcome of Empagliflozin in Pediatric Heart Failure Patients
Phase 2 · 1 location(s) · Ain Shams University · NCT07692256
The SMARTER Cardiomyopathy Study
Phase N/A · 2 location(s) · Imperial College London · NCT05750147
Registry of Cell Therapy in Non-Ischemic Dilated Cardiomyopathy
Phase N/A · 1 location(s) · University Medical Centre Ljubljana · NCT02445534
Dilated Cardiomyopathy Detection Using AI and Screening With Mobile Technology (DCM-DETECT)
NA · 1 location(s) · Lancaster General Hospital · NCT06688396
A Study of AZD4063 in PLN R14del Dilated Cardiomyopathy
Phase 1 · 4 location(s) · AstraZeneca · NCT07241104
Prognostic Values of Coronary Microvascular Dysfunction in Patients With Dilated Cardiomyopathy
Phase N/A · 1 location(s) · Second Affiliated Hospital, School of Medicine, Zhejiang Uni · NCT07293338
Natural History Study in Pediatric Patients With MYBPC3 Mutation-associated Cardiomyopathy
Phase N/A · 29 location(s) · Tenaya Therapeutics · NCT05112237
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.